Coronavirus company news summary – Study identifies biomarkers for Covid-19 blood screening tool – Jiaotong University develops rapid Covid-19 testing system

28 October 2020 (Last Updated October 28th, 2020 09:43)

Researchers from the Lawson Health Research Institute, Western University and University of Alberta study suggested that Covid-19 affects the concentration levels of specific metabolites in human blood. The team of researchers have identified three biomarkers that can be used an inexpensive and quick blood test to detect the presence of the virus in patients and predict patients likely to become critically ill.

Sixth Wave Innovations has received $250,000 from the Nova Scotia Covid-19 Response Council (NSCRC) to develop its Accelerated Molecularly Imprinted Polymer (AMIPs™) technology for rapid Covid-19 testing. The company aims to incorporate the technology into many rapid virus test kits, and in air and water monitoring schemes.

A Jiaotong University team has released a rapid screening test solution to detect the SARS-CoV-2 virus. The five-minute test helps identify antibodies against new coronary pneumonia. The test analyses the degree of the infection, a recent or prior infection, with the presence of the antibodies that can help in further diagnosis and treatment of the patient.

ICT International announced that it is making rapid antigen testing available to the UK and European markets. The test does not require expensive equipment or laboratories.